MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.jvca.2015.08.012

Медицинская библиотека · Journal of cardiothoracic and vascular anesthesia · 2015

Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.

Felli Alessia, Zeidler Petra, Jilma Bernd, Opfermann Philipp, Holaubek Caroline, Zimpfer Daniel, Wadowski Patricia P, Steinlechner Barbara

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Prothrombin complex concentrates (PCCs) are used to rapidly reverse anticoagulation by oral vitamin K antagonists. They differ in the content of clotting factors, endogenous anticoagulants, and heparin. The authors hypothesized that PCCs' specific heparin content may compromise the hemostatic effect.

DESIGN

Prospective ex-vivo investigation.

SETTING

University hospital.

PARTICIPANTS

Venous blood samples were obtained from 8 patients with implanted ventricular assist devices who also were receiving phenprocoumon.

INTERVENTIONS: Four different 4-factor PCCs were added to patient blood to attain a calculated increase in prothrombin time by 20%, 40%, and 60% greater than baseline in paired experiments.

MEASUREMENTS AND MAIN

RESULTS

Clotting was measured using thromboelastometry and endogenous thrombin potential. Two heparin-containing PCCs prolonged the clotting times in a concentration-dependent manner compared with baseline (p<0.01) and compared with PCCs containing significantly less or no heparin (p<0.01). The PCCs containing low or no heparin enhanced the area under the curve of thrombin generation and peak thrombin several fold relative to the heparin-containing PCCs (p<0.01). One of the PCCs containing heparin even decreased peak thrombin generation by ~90% compared with baseline (p<0.01). PCC with low or no heparin shortened the lag phase (p<0.01), whereas 1 heparin containing PCC prolonged the lag phase by 66% (p<0.01).

CONCLUSIONS

Physicians should be aware of the differences in heparin contents. Extrapolation of results from one agent to other PCC preparations may be difficult. Patients with an implanted left ventricular assist device and anticoagulated with vitamin-K antagonists could benefit from the use of PCC with low heparin content when surgery or bleeding requires emergency reversal. Further clinical studies are warranted.

Для цитирования: Felli Alessia, Zeidler Petra, Jilma Bernd, Opfermann Philipp, Holaubek Caroline, Zimpfer Daniel, Wadowski Patricia P, Steinlechner Barbara. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.. Journal of cardiothoracic and vascular anesthesia. 2015. DOI: 10.1053/j.jvca.2015.08.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.